TTrialPathMatch Me to Trials
← Back to trials
RecruitingHeart FailureDiuretic Resistance

Mechanisms of Diuretic Resistance in Heart Failure, Aim 3

Eligible age

18+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Randomized double-blind placebo-controlled crossover study design

Sponsor: Yale University

You may qualify if…

  • ✓ Clinical diagnosis of heart failure
  • ✓ No plan for titration/change of heart failure medical or device therapies during the study period.
  • ✓ Absence of non-elective hospitalizations in the previous 2 months.
  • ✓ At optimal volume status by symptoms, exam, and dry weight.
  • ✓ Serum potassium ≤ 5.0 mmol/L
  • ✓ Serum sodium ≥ 130 milliequivalents/ liter (mEq/L)
  • ✓ Hemoglobin ≥8 g/dL
  • ✓ Age \>18 years

You may not qualify if…

  • ✕ Glomerular filtration rate (GFR) \<20 ml/min/1.73m2
  • ✕ Use of any non-loop type diuretic in the last 7 days with the exclusion of low dose aldosterone antagonist (e.g., spironolactone ≤50 mg)
  • ✕ History of flash pulmonary edema or a "brittle" volume sensitive HF phenotype such as amyloid cardiomyopathy
  • ✕ Hemoglobin \< 8 g/dL
  • ✕ Pregnant or breastfeeding
  • ✕ Cirrhosis or known liver disease
  • ✕ History of metabolic or respiratory acidosis within 30 days
  • ✕ Use of metformin, acetazolamide, or any other agent that could predispose to acidosis

Where it's recruiting

Connecticut

New Haven

Source: ClinicalTrials.gov · NCT06209359 · last updated 2026-05-22

Mechanisms of Diuretic Resistance in Heart Failure, Aim 3 · TrialPath